{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:13:17Z","timestamp":1792800797757,"version":"4.5.0"},"reference-count":229,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T00:00:00Z","timestamp":1725580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T00:00:00Z","timestamp":1725580800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Neurodegener"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Neurodegenerative disorders are typically \u201csplit\u201d based on their hallmark clinical, anatomical, and pathological features, but they can also be \u201clumped\u201d by a shared feature of impaired mitochondrial biology. This leads us to present a scientific framework that conceptualizes Alzheimer\u2019s disease (AD), Parkinson\u2019s disease (PD), amyotrophic lateral sclerosis (ALS), and Huntington\u2019s disease (HD) as \u201cmetabolic icebergs\u201d comprised of a tip, a bulk, and a base. The visible tip conveys the hallmark neurological symptoms, neurodegenerative regions, and neuronal protein aggregates for each disorder. The hidden bulk depicts impaired mitochondrial biology throughout the body, which is multifaceted and may be subdivided into impaired cellular metabolism, cell-specific mitotypes, and mitochondrial behaviours, functions, activities, and features. The underlying base encompasses environmental factors, especially modern industrial toxins, dietary lifestyles, and cognitive, physical, and psychosocial behaviours, but also accommodates genetic factors specific to familial forms of AD, PD, and ALS, as well as HD. Over years or decades, chronic exposure to a particular suite of environmental and genetic factors at the base elicits a trajectory of impaired mitochondrial biology that maximally impacts particular subsets of mitotypes in the bulk, which eventually surfaces as the hallmark features of a particular neurodegenerative disorder at the tip. We propose that impaired mitochondrial biology can be repaired and recalibrated by activating \u201cmitohormesis\u201d, which is optimally achieved using strategies that facilitate a balanced oscillation between mitochondrial stressor and recovery phases. Sustainably harnessing mitohormesis may constitute a potent preventative and therapeutic measure for people at risk of, or suffering with, neurodegenerative disorders.<\/jats:p>","DOI":"10.1186\/s40035-024-00435-8","type":"journal-article","created":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T00:02:24Z","timestamp":1725580944000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Neurodegenerative disorders, metabolic icebergs, and mitohormesis"],"prefix":"10.1186","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4183-7766","authenticated-orcid":false,"given":"Matthew C. L.","family":"Phillips","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2835-0478","authenticated-orcid":false,"given":"Martin","family":"Picard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,6]]},"reference":[{"key":"435_CR1","unstructured":"Ovid. Metamorphoses. Hugo Magnus (Ed.). Gotha (Germany). Friedr. Andr. Perthes. 1892."},{"key":"435_CR2","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","volume":"392","author":"GBD 2017 Disease and Injury Incidence and Prevalence Collaborators","year":"2018","unstructured":"GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1789\u2013858.","journal-title":"Lancet"},{"key":"435_CR3","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","volume":"7","author":"GBD 2019 Dementia Forecasting Collaborators","year":"2022","unstructured":"GBD 2019 Dementia Forecasting Collaborators. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health. 2022;7:e105\u201325.","journal-title":"Lancet Public Health"},{"key":"435_CR4","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S1474-4422(18)30295-3","volume":"17","author":"GBD 2016 Parkinson\u2019s Disease Collaborators","year":"2018","unstructured":"GBD 2016 Parkinson\u2019s Disease Collaborators. Global, regional, and national burden of Parkinson\u2019s disease, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018;17:939\u201353.","journal-title":"Lancet Neurol"},{"key":"435_CR5","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1097\/WCO.0000000000000730","volume":"32","author":"E Longinetti","year":"2019","unstructured":"Longinetti E, Fang F. Epidemiology of amyotrophic lateral sclerosis: an update of recent literature. Curr Opin Neurol. 2019;32:771\u20136.","journal-title":"Curr Opin Neurol"},{"key":"435_CR6","doi-asserted-by":"publisher","first-page":"12408","DOI":"10.1038\/ncomms12408","volume":"7","author":"KC Arthur","year":"2016","unstructured":"Arthur KC, Calvo A, Price TR, Geiger JT, Chi\u00f2 A, Traynor BJ. Projected increase in amyotrophic lateral sclerosis from 2015 to 2040. Nat Commun. 2016;7:12408.","journal-title":"Nat Commun"},{"key":"435_CR7","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1002\/mds.29228","volume":"37","author":"A Medina","year":"2022","unstructured":"Medina A, Mahjoub Y, Shaver L, Pringsheim T. Prevalence and incidence of Huntington\u2019s disease: an updated systematic review and meta-analysis. Mov Disord. 2022;37:2327\u201335.","journal-title":"Mov Disord"},{"key":"435_CR8","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1093\/toxsci\/kfr239","volume":"124","author":"JR Cannon","year":"2011","unstructured":"Cannon JR, Greenamyre JT. The role of environmental exposures in neurodegeneration and neurodegenerative diseases. Toxicol Sci. 2011;124:225\u201350.","journal-title":"Toxicol Sci"},{"key":"435_CR9","doi-asserted-by":"publisher","first-page":"655","DOI":"10.14336\/AD.2021.1018","volume":"13","author":"MC Phillips","year":"2022","unstructured":"Phillips MC. Metabolic strategies in healthcare: a new era. Aging Dis. 2022;13:655\u201372.","journal-title":"Aging Dis"},{"key":"435_CR10","unstructured":"Darwin Correspondence Project. \u201cLetter No 2130\u201d. https:\/\/www.darwinproject.ac.uk\/letter\/?docId=letters\/DCP-LETT-2130.xml. Accessed 4 Mar 2024."},{"key":"435_CR11","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1056\/NEJMms1706744","volume":"377","author":"JA Greene","year":"2017","unstructured":"Greene JA, Loscalzo J. Putting the patient back together\u2014social medicine, network medicine, and the limits of reductionism. N Engl J Med. 2017;377:2493\u20139.","journal-title":"N Engl J Med"},{"key":"435_CR12","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a028035","volume":"9","author":"BN Dugger","year":"2017","unstructured":"Dugger BN, Dickson DW. Pathology of neurodegenerative diseases. Cold Spring Harb Perspect Biol. 2017;9: a028035.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"435_CR13","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1007\/s10072-013-1424-7","volume":"34","author":"F Raudino","year":"2013","unstructured":"Raudino F. Non-cognitive symptoms and related conditions in the Alzheimer\u2019s disease: a literature review. Neurol Sci. 2013;34:1275\u201382.","journal-title":"Neurol Sci"},{"key":"435_CR14","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.cmet.2015.08.016","volume":"22","author":"M Ishii","year":"2015","unstructured":"Ishii M, Iadecola C. Metabolic and non-cognitive manifestations of Alzheimer\u2019s disease: the hypothalamus as both culprit and target of pathology. Cell Metab. 2015;22:761\u201376.","journal-title":"Cell Metab"},{"key":"435_CR15","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S1474-4422(06)70373-8","volume":"5","author":"KR Chaudhuri","year":"2006","unstructured":"Chaudhuri KR, Healy DG, Schapira AHV, National Institute for Clinical Excellence. Non-motor symptoms of Parkinson\u2019s disease: diagnosis and management. Lancet Neurol. 2006;5:235\u201345.","journal-title":"Lancet Neurol"},{"key":"435_CR16","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/mds.23795","volume":"27","author":"KA Jellinger","year":"2012","unstructured":"Jellinger KA. Neuropathology of sporadic Parkinson\u2019s disease: evaluation and changes of concepts. Mov Disord. 2012;27:8\u201330.","journal-title":"Mov Disord"},{"key":"435_CR17","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/WCO.0000000000000862","volume":"33","author":"N Pender","year":"2020","unstructured":"Pender N, Pinto-Grau M, Hardiman O. Cognitive and behavioural impairment in amyotrophic lateral sclerosis. Curr Opin Neurol. 2020;33:649\u201354.","journal-title":"Curr Opin Neurol"},{"key":"435_CR18","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/S2215-0366(16)30144-4","volume":"3","author":"CM Eddy","year":"2016","unstructured":"Eddy CM, Parkinson EG, Rickards HE. Changes in mental state and behaviour in Huntington\u2019s disease. Lancet Psychiatry. 2016;3:1079\u201386.","journal-title":"Lancet Psychiatry"},{"key":"435_CR19","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1001\/archneur.65.5.636","volume":"65","author":"F Geser","year":"2008","unstructured":"Geser F, Brandmeir NJ, Kwong LK, Martinez-Lage M, Elman L, McCluskey L, et al. Evidence of multisystem disorder in whole-brain map of pathological TDP-43 in amyotrophic lateral sclerosis. Arch Neurol. 2008;65:636\u201341.","journal-title":"Arch Neurol"},{"key":"435_CR20","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1111\/bpa.12426","volume":"26","author":"U R\u00fcb","year":"2016","unstructured":"R\u00fcb U, Seidel K, Heinsen H, Vonsattel JP, den Dunnen WF, Korf HW. Huntington\u2019s disease (HD): the neuropathology of a multisystem neurodegenerative disorder of the human brain. Brain Pathol. 2016;26:726\u201340.","journal-title":"Brain Pathol"},{"key":"435_CR21","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1097\/00005072-199908000-00003","volume":"58","author":"J Miklossy","year":"1999","unstructured":"Miklossy J, Taddei K, Martins R, Escher G, Kraftsik R, Pillevuit O, et al. Alzheimer disease: curly fibers and tangles in organs other than brain. J Neuropathol Exp Neurol. 1999;58:803\u201314.","journal-title":"J Neuropathol Exp Neurol"},{"key":"435_CR22","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1002\/mds.22172","volume":"24","author":"R Djaldetti","year":"2009","unstructured":"Djaldetti R, Lev N, Melamed E. Lesions outside the CNS in Parkinson\u2019s disease. Mov Disord. 2009;24:793\u2013800.","journal-title":"Mov Disord"},{"key":"435_CR23","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s40478-019-0824-1","volume":"7","author":"F Mori","year":"2019","unstructured":"Mori F, Tada M, Kon T, Miki Y, Tanji K, Kurotaki H, et al. Phosphorylated TDP-43 aggregates in skeletal and cardiac muscle are a marker of myogenic degeneration in amyotrophic lateral sclerosis and various conditions. Acta Neuropathol Commun. 2019;7:165.","journal-title":"Acta Neuropathol Commun"},{"key":"435_CR24","first-page":"325","volume":"2","author":"GC Melkani","year":"2016","unstructured":"Melkani GC. Huntington\u2019s disease-induced cardiac disorders affect multiple cellular pathways. React Oxyg Species (Apex). 2016;2:325\u201338.","journal-title":"React Oxyg Species (Apex)"},{"key":"435_CR25","doi-asserted-by":"publisher","first-page":"4260","DOI":"10.1016\/j.cell.2023.08.021","volume":"186","author":"M Jucker","year":"2023","unstructured":"Jucker M, Walker LC. Alzheimer\u2019s disease: from immunotherapy to immunoprevention. Cell. 2023;186:4260\u201370.","journal-title":"Cell"},{"key":"435_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2019.104587","volume":"132","author":"D Chatterjee","year":"2019","unstructured":"Chatterjee D, Kordower JH. Immunotherapy in Parkinson\u2019s disease: current status and future directions. Neurobiol Dis. 2019;132: 104587.","journal-title":"Neurobiol Dis"},{"key":"435_CR27","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.jclinepi.2022.04.017","volume":"148","author":"J Howick","year":"2022","unstructured":"Howick J, Koletsi D, Ioannidis JPA, Madigan C, Pandis N, Loef M, et al. Most healthcare interventions tested in cochrane reviews are not effective according to high quality evidence: a systematic review and meta-analysis. J Clin Epidemiol. 2022;148:160\u20139.","journal-title":"J Clin Epidemiol"},{"key":"435_CR28","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1002\/ana.20624","volume":"58","author":"MF Beal","year":"2005","unstructured":"Beal MF. Mitochondria take center stage in aging and neurodegeneration. Ann Neurol. 2005;58:495\u2013505.","journal-title":"Ann Neurol"},{"key":"435_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurot.2023.10.002","volume":"21","author":"MM Klemmensen","year":"2024","unstructured":"Klemmensen MM, Borrowman SH, Pearce C, Pyles B. Mitochondrial dysfunction in neurodegenerative disorders. Neurotherapeutics. 2024;21: e00292.","journal-title":"Neurotherapeutics"},{"key":"435_CR30","first-page":"426","volume":"10","author":"G Manfredi","year":"2000","unstructured":"Manfredi G, Beal MF. The role of mitochondria in the pathogenesis of neurodegenerative diseases. CNS Spectr. 2000;10:426\u201372.","journal-title":"CNS Spectr"},{"key":"435_CR31","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/s42255-023-00783-1","volume":"5","author":"AS Monzel","year":"2023","unstructured":"Monzel AS, Enr\u00edquez JA, Picard M. Multifaceted mitochondria: moving mitochondrial science beyond function and dysfunction. Nat Metab. 2023;5:546\u201362.","journal-title":"Nat Metab"},{"key":"435_CR32","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1016\/j.cmet.2022.10.008","volume":"34","author":"M Picard","year":"2022","unstructured":"Picard M, Shirihai OS. Mitochondrial signal transduction. Cell Metab. 2022;34:1620\u201353.","journal-title":"Cell Metab"},{"key":"435_CR33","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41467-019-13668-3","volume":"11","author":"I Mart\u00ednez-Reyes","year":"2020","unstructured":"Mart\u00ednez-Reyes I, Chandel NS. Mitochondrial TCA cycle metabolites control physiology and disease. Nat Commun. 2020;11:102.","journal-title":"Nat Commun"},{"key":"435_CR34","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.freeradbiomed.2020.11.016","volume":"170","author":"JH Santos","year":"2021","unstructured":"Santos JH. Mitochondria signaling to the epigenome: a novel role for an old organelle. Free Radic Biol Med. 2021;170:59\u201369.","journal-title":"Free Radic Biol Med"},{"key":"435_CR35","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1038\/s41593-019-0479-z","volume":"10","author":"C Fecher","year":"2019","unstructured":"Fecher C, Trov\u00f2 L, M\u00fcller SA, Snaidero N, Wettmarshausen J, Heink S, et al. Cell-type-specific profiling of brain mitochondria reveals functional and molecular diversity. Nat Neurosci. 2019;10:1731\u201342.","journal-title":"Nat Neurosci"},{"key":"435_CR36","doi-asserted-by":"publisher","DOI":"10.1101\/2024.03.05.583623","author":"EV Mosharov","year":"2024","unstructured":"Mosharov EV, Rosenberg AM, Monzel AS, Osto CA, Stiles L, Rosoklija GB, et al. A human brain map of mitochondrial respiratory capacity and diversity. bioRxiv. 2024. https:\/\/doi.org\/10.1101\/2024.03.05.583623.","journal-title":"bioRxiv"},{"key":"435_CR37","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.70899","volume":"10","author":"S Rausser","year":"2021","unstructured":"Rausser S, Trumpff C, McGill MA, Junker A, Wang W, Ho S, et al. Mitochondrial phenotypes in purified human immune cell subtypes and cell mixtures. Elife. 2021;10: e70899.","journal-title":"Elife"},{"key":"435_CR38","doi-asserted-by":"publisher","first-page":"4726","DOI":"10.1038\/s41467-023-39941-0","volume":"14","author":"AM Rosenberg","year":"2023","unstructured":"Rosenberg AM, Saggar M, Monzel AS, Devine J, Rogu P, Limoges A, et al. Brain mitochondrial diversity and network organization predict anxiety-like behavior in male mice. Nat Commun. 2023;14:4726.","journal-title":"Nat Commun"},{"key":"435_CR39","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.mito.2023.04.003","volume":"70","author":"RK Naviaux","year":"2023","unstructured":"Naviaux RK. Mitochondrial and metabolic features of salugenesis and the healing cycle. Mitochondrion. 2023;70:131\u201363.","journal-title":"Mitochondrion"},{"key":"435_CR40","doi-asserted-by":"publisher","first-page":"S385","DOI":"10.4103\/2152-7806.140191","volume":"5","author":"JLB Pereira","year":"2014","unstructured":"Pereira JLB, Downes A, Gorgulho A, Patel V, Malkasian D, De Salles A. Alzheimer\u2019s disease: the role for neurosurgery. Surg Neurol Int. 2014;5:S385\u201390.","journal-title":"Surg Neurol Int"},{"key":"435_CR41","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1007\/s13311-020-00939-x","volume":"17","author":"VD Sharma","year":"2020","unstructured":"Sharma VD, Patel M, Miocinovic S. Surgical treatment of Parkinson\u2019s disease: devices and lesion approaches. Neurotherapeutics. 2020;17:1525\u201338.","journal-title":"Neurotherapeutics"},{"key":"435_CR42","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.nut.2010.07.021","volume":"27","author":"S Cunnane","year":"2011","unstructured":"Cunnane S, Nugent S, Roy M, Courchesne-Loyer A, Croteau E, Tremblay S, et al. Brain fuel metabolism, aging, and Alzheimer\u2019s disease. Nutrition. 2011;27:3\u201320.","journal-title":"Nutrition"},{"key":"435_CR43","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/mds.26907","volume":"32","author":"AP Strafella","year":"2017","unstructured":"Strafella AP, Bohnen NI, Perlmutter JS, Eidelberg D, Pavese N, Eimeren TV, et al. Molecular imaging to track Parkinson\u2019s disease and atypical parkinsonisms: new imaging frontiers. Mov Disord. 2017;32:181\u201392.","journal-title":"Mov Disord"},{"key":"435_CR44","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1212\/WNL.0000000000000792","volume":"83","author":"M Pagani","year":"2014","unstructured":"Pagani M, Chi\u00f2 A, Valentini MC, \u00d6berg J, Nobili F, Calvo A, et al. Functional pattern of brain FDG-PET in amyotrophic lateral sclerosis. Neurology. 2014;83:1067\u201374.","journal-title":"Neurology"},{"key":"435_CR45","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1007\/s00259-016-3445-y","volume":"43","author":"DA L\u00f3pez-Mora","year":"2016","unstructured":"L\u00f3pez-Mora DA, Camacho V, P\u00e9rez-P\u00e9rez J, Mart\u00ednez-Horta S, Fern\u00e1ndez A, Sampedro F, et al. Striatal hypometabolism in premanifest and manifest Huntington\u2019s disease patients. Eur J Nucl Med Mol Imaging. 2016;43:2183\u20139.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"435_CR46","doi-asserted-by":"publisher","first-page":"278","DOI":"10.3389\/fncel.2020.00278","volume":"14","author":"R Stevenson","year":"2020","unstructured":"Stevenson R, Samokhina E, Rossetti I, Morley JW, Buskila Y. Neuromodulation of glial function during neurodegeneration. Front Cell Neurosci. 2020;14:278.","journal-title":"Front Cell Neurosci"},{"key":"435_CR47","doi-asserted-by":"publisher","first-page":"4436","DOI":"10.1002\/alz.13388","volume":"19","author":"Q Tian","year":"2023","unstructured":"Tian Q, Bilgel M, Walker KA, Moghekar AR, Fishbein KW, Spencer RG, et al. Skeletal muscle mitochondrial function predicts cognitive impairment and is associated with biomarkers of Alzheimer\u2019s disease and neurodegeneration. Alzheimer\u2019s Dement. 2023;19:4436\u201345.","journal-title":"Alzheimer\u2019s Dement"},{"key":"435_CR48","first-page":"493","volume":"47","author":"S Landin","year":"1974","unstructured":"Landin S, Hagenfeldt L, Saltin B, Wahren J. Muscle metabolism during exercise in patients with Parkinson\u2019s disease. Clin Sci Mol Med. 1974;47:493\u2013506.","journal-title":"Clin Sci Mol Med"},{"key":"435_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/toxsci\/kft102","volume":"134","author":"JN Meyer","year":"2013","unstructured":"Meyer JN, Leung MCK, Rooney JP, Sendoel A, Hengartner MO, Kisby GE, et al. Mitochondria as a target of environmental toxicants. Toxicol Sci. 2013;134:1\u201317.","journal-title":"Toxicol Sci"},{"key":"435_CR50","doi-asserted-by":"publisher","first-page":"672","DOI":"10.2337\/db12-1203","volume":"62","author":"M Picard","year":"2013","unstructured":"Picard M, Turnbull DM. Linking the metabolic state and mitochondrial DNA in chronic disease, health, and aging. Diabetes. 2013;62:672\u20138.","journal-title":"Diabetes"},{"key":"435_CR51","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1097\/PSY.0000000000000544","volume":"80","author":"M Picard","year":"2018","unstructured":"Picard M, McEwen BS. Psychological stress and mitochondria: a conceptual framework. Psychosom Med. 2018;80:126\u201340.","journal-title":"Psychosom Med"},{"key":"435_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2020.113321","volume":"330","author":"IW Weidling","year":"2020","unstructured":"Weidling IW, Swerdlow RH. Mitochondria in Alzheimer\u2019s disease and their potential role in Alzheimer\u2019s proteostasis. Exp Neurol. 2020;330: 113321.","journal-title":"Exp Neurol"},{"key":"435_CR53","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.tins.2014.03.004","volume":"37","author":"LA Scarffe","year":"2014","unstructured":"Scarffe LA, Stevens DA, Dawson VL, Dawson TM. Parkin and PINK1: much more than mitophagy. Trends Neurosci. 2014;37:315\u201324.","journal-title":"Trends Neurosci"},{"key":"435_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2017.06.052","volume":"710","author":"EF Smith","year":"2019","unstructured":"Smith EF, Shaw PJ, De Vos KJ. The role of mitochondria in amyotrophic lateral sclerosis. Neurosci Lett. 2019;710: 132933.","journal-title":"Neurosci Lett"},{"key":"435_CR55","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.mito.2023.03.001","volume":"70","author":"Y Dai","year":"2023","unstructured":"Dai Y, Wang H, Lian A, Li J, Zhao G, Hu S, et al. A comprehensive perspective of Huntington\u2019s disease and mitochondrial dysfunction. Mitochondrion. 2023;70:8\u201319.","journal-title":"Mitochondrion"},{"key":"435_CR56","doi-asserted-by":"publisher","first-page":"116","DOI":"10.2174\/1567205012666150204121719","volume":"12","author":"M Yegambaram","year":"2015","unstructured":"Yegambaram M, Manivannan B, Beach TG, Halden RU. Role of environmental contaminants in the etiology of Alzheimer\u2019s disease: a review. Curr Alzheimer Res. 2015;12:116\u201346.","journal-title":"Curr Alzheimer Res"},{"key":"435_CR57","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1146\/annurev-pharmtox-011613-135937","volume":"54","author":"SM Goldman","year":"2014","unstructured":"Goldman SM. Environmental toxins and Parkinson\u2019s disease. Annu Rev Pharmacol Toxicol. 2014;54:141\u201364.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"435_CR58","first-page":"181","volume":"7","author":"C Ingre","year":"2015","unstructured":"Ingre C, Roos PM, Piehl F, Kamel F, Fang F. Risk factors for amyotrophic lateral sclerosis. Clin Epidemiol. 2015;7:181\u201393.","journal-title":"Clin Epidemiol"},{"key":"435_CR59","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/ana.410380304","volume":"38","author":"MF Beal","year":"1995","unstructured":"Beal MF. Aging, energy, and oxidative stress in neurodegenerative diseases. Ann Neurol. 1995;38:357\u201366.","journal-title":"Ann Neurol"},{"key":"435_CR60","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1093\/jnen\/60.8.759","volume":"60","author":"A Nunomura","year":"2001","unstructured":"Nunomura A, Perry G, Aliev G, Hirai K, Takeda A, Balraj EK, et al. Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol. 2001;60:759\u201367.","journal-title":"J Neuropathol Exp Neurol"},{"key":"435_CR61","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1113\/jphysiol.2003.049478","volume":"15","author":"JF Turrens","year":"2003","unstructured":"Turrens JF. Mitochondrial formation of reactive oxygen species. J Physiol. 2003;15:335\u201344.","journal-title":"J Physiol"},{"key":"435_CR62","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1084\/jem.192.7.1001","volume":"192","author":"DB Zorov","year":"2000","unstructured":"Zorov DB, Filburn CR, Klotz LO, Zweier JL, Sollott SJ. Reactive oxygen species (ROS)-induced ROS release: a new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes. J Exp Med. 2000;192:1001\u201314.","journal-title":"J Exp Med"},{"key":"435_CR63","doi-asserted-by":"publisher","first-page":"1347987","DOI":"10.3389\/fnagi.2024.1347987","volume":"16","author":"A Adamu","year":"2024","unstructured":"Adamu A, Li S, Gao F, Xue G. The role of neuroinflammation in neurodegenerative diseases: current understanding and future therapeutic targets. Front Aging Neurosci. 2024;16:1347987.","journal-title":"Front Aging Neurosci"},{"key":"435_CR64","doi-asserted-by":"publisher","first-page":"5938","DOI":"10.3390\/ijms23115938","volume":"23","author":"DM Teleanu","year":"2022","unstructured":"Teleanu DM, Niculescu A, Lungu II, Radu CI, Vlad\u00e2cenco O, Roza E, et al. An overview of oxidative stress, neuroinflammation, and neurodegenerative diseases. Int J Mol Sci. 2022;23:5938.","journal-title":"Int J Mol Sci"},{"key":"435_CR65","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/jnc.14471","volume":"147","author":"M Audano","year":"2018","unstructured":"Audano M, Schneider A, Mitro N. Mitochondria, lysosomes, and dysfunction: their meaning in neurodegeneration. J Neurochem. 2018;147:291\u2013309.","journal-title":"J Neurochem"},{"key":"435_CR66","doi-asserted-by":"publisher","first-page":"4118","DOI":"10.1093\/hmg\/ddx299","volume":"26","author":"W Wang","year":"2017","unstructured":"Wang W, Yin J, Ma X, Zhao F, Siedlak SL, Wang Z, et al. Inhibition of mitochondrial fragmentation protects against Alzheimer\u2019s disease in rodent model. Human Mol Genet. 2017;26:4118\u201331.","journal-title":"Human Mol Genet"},{"key":"435_CR67","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1093\/hmg\/ddab363","volume":"31","author":"F Du","year":"2022","unstructured":"Du F, Yu Q, Kanaan NM, Yan SS. Mitochondrial oxidative stress contributes to the pathological aggregation and accumulation of tau oligomers in Alzheimer\u2019s disease. Hum Mol Genet. 2022;31:2498\u2013507.","journal-title":"Hum Mol Genet"},{"key":"435_CR68","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1126\/science.aam9080","volume":"357","author":"LF Burbulla","year":"2017","unstructured":"Burbulla LF, Song P, Mazzulli JR, Zampese E, Wong YC, Jeon S. Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson\u2019s disease. Science. 2017;357:1255\u201361.","journal-title":"Science"},{"key":"435_CR69","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.3390\/antiox11122466","volume":"11","author":"SK Won","year":"2022","unstructured":"Won SK, Fong R, Butler N, Sanchez J, Zhang Y, Wong C, et al. Neuronal oxidative stress promotes \u03b1-synuclein aggregation in vivo. Antioxidants. 2022;11:2466.","journal-title":"Antioxidants"},{"key":"435_CR70","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s00401-011-0850-y","volume":"122","author":"V Ayala","year":"2011","unstructured":"Ayala V, Granado-Serrano AB, Cacabelos D, Naud\u00ed A, Ilieva E, Boada J, et al. Cell stress induces TDP-43 pathological changes associated with ERK1\/2 dysfunction: implications in ALS. Acta Neuropathol. 2011;122:259\u201370.","journal-title":"Acta Neuropathol"},{"key":"435_CR71","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.nbd.2011.12.002","volume":"45","author":"Y Iguchi","year":"2012","unstructured":"Iguchi Y, Katsuno M, Takagi S, Ishigaki S, Niwa J, Hasegawa M. Oxidative stress induced by glutathione depletion reproduces pathological modifications of TDP-43 linked to TDP-43 proteinopathies. Neurobiol Dis. 2012;45:862\u201370.","journal-title":"Neurobiol Dis"},{"key":"435_CR72","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1042\/BST20170024","volume":"45","author":"AY Abramov","year":"2017","unstructured":"Abramov AY, Berezhnov AV, Fedotova EI, Zinchenko VP, Dolgacheva LP. Interaction of misfolded proteins and mitochondria in neurodegenerative disorders. Biochem Soc Trans. 2017;45:1025\u201333.","journal-title":"Biochem Soc Trans"},{"key":"435_CR73","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1007\/s00415-009-0062-8","volume":"255","author":"NA Aziz","year":"2009","unstructured":"Aziz NA, van der Marck MA, Pijl H, Rikkert MGMO, Bloem BR, Roos RAC. Weight loss in neurodegenerative disorders. J Neurol. 2009;255:1872\u201380.","journal-title":"J Neurol"},{"key":"435_CR74","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12929-019-0524-y","volume":"26","author":"MVF Silva","year":"2019","unstructured":"Silva MVF, Loures CMG, Alves LCV, de Souza LC, Borges KBG, Carvalho MG. Alzheimer\u2019s disease: risk factors and potentially protective measures. J Biomed Sci. 2019;26:33.","journal-title":"J Biomed Sci"},{"key":"435_CR75","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0140-6736(20)30367-6","volume":"396","author":"G Livingston","year":"2020","unstructured":"Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 2020;396:413\u201346.","journal-title":"Lancet"},{"key":"435_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.conb.2023.102684","volume":"79","author":"RW Mahley","year":"2023","unstructured":"Mahley RW. Apolipoprotein E4 targets mitochondria and the mitochondria-associated membrane complex in neuropathology, including Alzheimer\u2019s disease. Curr Opin Neurobiol. 2023;79: 102684.","journal-title":"Curr Opin Neurobiol"},{"key":"435_CR77","doi-asserted-by":"publisher","first-page":"9057","DOI":"10.1523\/JNEUROSCI.1469-06.2006","volume":"26","author":"L Devi","year":"2006","unstructured":"Devi L, Prabhu BM, Galati DF, Avadhani NG, Anandatheerthavarada HK. Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer\u2019s disease brain Is associated with mitochondrial dysfunction. J Neurosci. 2006;26:9057\u201368.","journal-title":"J Neurosci"},{"key":"435_CR78","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.ceca.2016.02.013","volume":"59","author":"P Toglia","year":"2016","unstructured":"Toglia P, Cheung K, Mak DD, Ullah G. Impaired mitochondrial function due to familial Alzheimer\u2019s disease-causing presenilins mutants via Ca(2+) disruptions. Cell Calcium. 2016;59:240\u201350.","journal-title":"Cell Calcium"},{"key":"435_CR79","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.3233\/JAD-170585","volume":"62","author":"RH Swerdlow","year":"2018","unstructured":"Swerdlow RH. Mitochondria and mitochondrial cascades in Alzheimer\u2019s disease. J Alzheimers Dis. 2018;62:1403\u201316.","journal-title":"J Alzheimers Dis"},{"key":"435_CR80","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3233\/JAD-2005-7107","volume":"7","author":"E Steen","year":"2005","unstructured":"Steen E, Terry BM, Rivera EJ, Cannon JL, Neely TR, Ravares R, et al. Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer\u2019s disease\u2014Is this type 3 diabetes? J Alzheimers Dis. 2005;7:63\u201380.","journal-title":"J Alzheimers Dis"},{"key":"435_CR81","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.1523\/JNEUROSCI.21-09-03017.2001","volume":"21","author":"K Hirai","year":"2001","unstructured":"Hirai K, Aliev G, Nunomura A, Fujioka H, Russell RL, Atwood CS, et al. Mitochondrial abnormalities in Alzheimer\u2019s disease. J Neurosci. 2001;21:3017\u201323.","journal-title":"J Neurosci"},{"key":"435_CR82","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1007\/s00401-018-1903-2","volume":"136","author":"EK Pickett","year":"2018","unstructured":"Pickett EK, Rose J, McCrory C, McKenzie C, King D, Smith C, et al. Region-specific depletion of synaptic mitochondria in the brains of patients with Alzheimer\u2019s disease. Acta Neuropathol. 2018;136:747\u201357.","journal-title":"Acta Neuropathol"},{"key":"435_CR83","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1093\/hmg\/ddr139","volume":"20","author":"M Manczak","year":"2011","unstructured":"Manczak M, Calkins MJ, Reddy PH. Impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with Alzheimer\u2019s disease: implications for neuronal damage. Hum Mol Genet. 2011;20:2495\u2013509.","journal-title":"Hum Mol Genet"},{"key":"435_CR84","doi-asserted-by":"publisher","first-page":"679","DOI":"10.3233\/JAD-160532","volume":"54","author":"Q Yu","year":"2016","unstructured":"Yu Q, Fang D, Swerdlow RH, Yu H, Chen JX, Yan SS. Antioxidants rescue mitochondrial transport in differentiated Alzheimer\u2019s disease trans-mitochondrial cybrid cells. J Alzheimers Dis. 2016;54:679\u201390.","journal-title":"J Alzheimers Dis"},{"key":"435_CR85","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/s41593-018-0332-9","volume":"22","author":"EF Fang","year":"2019","unstructured":"Fang EF, Hou Y, Palikaras K, Adriaanse BA, Kerr JS, Yang B, et al. Mitophagy inhibits amyloid-\u03b2 and tau pathology and reverses cognitive deficits in models of Alzheimer\u2019s disease. Nat Neurosci. 2019;22:401\u201312.","journal-title":"Nat Neurosci"},{"key":"435_CR86","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/j.1750-3639.2009.00266.x","volume":"20","author":"B Terni","year":"2010","unstructured":"Terni B, Boada J, Portero-Otin M, Pamplona R, Ferrer I. Mitochondrial ATP-synthase in the entorhinal cortex is a target of oxidative stress at stages I\/II of Alzheimer\u2019s disease pathology. Brain Pathol. 2010;20:222\u201333.","journal-title":"Brain Pathol"},{"issue":"Suppl 2","key":"435_CR87","doi-asserted-by":"publisher","first-page":"S487","DOI":"10.3233\/JAD-2010-100306","volume":"20","author":"C Supnet","year":"2010","unstructured":"Supnet C, Bezprozvanny I. Neuronal calcium signaling, mitochondrial dysfunction, and Alzheimer\u2019s disease. J Alzheimers Dis. 2010;20(Suppl 2):S487\u201398.","journal-title":"J Alzheimers Dis"},{"key":"435_CR88","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1046\/j.1471-4159.1994.63062179.x","volume":"63","author":"EM Mutisya","year":"1994","unstructured":"Mutisya EM, Bowling AC, Beal MF. Cortical cytochrome oxidase activity is reduced in Alzheimer\u2019s disease. J Neurochem. 1994;63:2179\u201384.","journal-title":"J Neurochem"},{"key":"435_CR89","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3233\/JAD-2006-9204","volume":"9","author":"SJ Baloyannis","year":"2006","unstructured":"Baloyannis SJ. Mitochondrial alterations in Alzheimer\u2019s disease. J Alzheimers Dis. 2006;9:119\u201326.","journal-title":"J Alzheimers Dis"},{"key":"435_CR90","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, et al. The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 2011;7:263\u20139.","journal-title":"Alzheimers Dement"},{"key":"435_CR91","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.exger.2018.01.002","volume":"107","author":"AD Henriques","year":"2018","unstructured":"Henriques AD, Benedet AL, Camargos EF, Rosa-Neto P, N\u00f3brega OT. Fluid and imaging biomarkers for Alzheimer\u2019s disease: where we stand and where to head to. Exp Gerontol. 2018;107:169\u201377.","journal-title":"Exp Gerontol"},{"key":"435_CR92","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1038\/81834","volume":"3","author":"R Betarbet","year":"2000","unstructured":"Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, Greenamayre JT. Chronic systemic pesticide exposure reproduces features of Parkinson\u2019s disease. Nat Neurosci. 2000;3:1301\u20136.","journal-title":"Nat Neurosci"},{"key":"435_CR93","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1126\/science.6823561","volume":"219","author":"JW Langston","year":"1983","unstructured":"Langston JW, Ballard P, Tetrud JW, Irwin I. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science. 1983;219:979\u201380.","journal-title":"Science"},{"key":"435_CR94","doi-asserted-by":"publisher","first-page":"6405278","DOI":"10.1155\/2017\/6405278","volume":"2017","author":"LK Mischley","year":"2017","unstructured":"Mischley LK, Lau RC, Bennett RD. Role of diet and nutritional supplements in Parkinson\u2019s disease progression. Oxid Med Cell Longev. 2017;2017:6405278.","journal-title":"Oxid Med Cell Longev"},{"key":"435_CR95","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2019.104671","volume":"134","author":"D Belvisi","year":"2020","unstructured":"Belvisi D, Pellicciari R, Fabbrini G, Tinazzi M, Berardelli A, Defazio G. Modifiable risk and protective factors in disease development, progression and clinical subtypes of Parkinson\u2019s disease: What do prospective studies suggest? Neurobiol Dis. 2020;134: 104671.","journal-title":"Neurobiol Dis"},{"key":"435_CR96","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1001\/jamaneurol.2023.3382","volume":"80","author":"A Terracciano","year":"2023","unstructured":"Terracciano A, Luchetti M, Karakose S, Stephan Y, Sutin AR. Loneliness and risk of Parkinson disease. JAMA Neurol. 2023;80:1138\u201344.","journal-title":"JAMA Neurol"},{"key":"435_CR97","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/33416","volume":"392","author":"T Kitada","year":"1998","unstructured":"Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S, et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature. 1998;392:605\u20138.","journal-title":"Nature"},{"key":"435_CR98","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1126\/science.1096284","volume":"304","author":"EM Valente","year":"2004","unstructured":"Valente EM, Abou-Sleiman PM, Caputo V, Muqit MMK, Harvey K, Gispert S, et al. Hereditary early-onset Parkinson\u2019s disease caused by mutations in PINK1. Science. 2004;304:1158\u201360.","journal-title":"Science"},{"issue":"Suppl 1","key":"435_CR99","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/jnc.13731","volume":"139","author":"A Bose","year":"2016","unstructured":"Bose A, Beal MF. Mitochondrial dysfunction in Parkinson\u2019s disease. J Neurochem. 2016;139(Suppl 1):216\u201331.","journal-title":"J Neurochem"},{"key":"435_CR100","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.bbadis.2013.10.003","volume":"1842","author":"AR Esteves","year":"2014","unstructured":"Esteves AR, Gozes I, Cardoso SM. The rescue of microtubule-dependent traffic recovers mitochondrial function in Parkinson\u2019s disease. Biochim Biophys Acta. 2014;1842:7\u201321.","journal-title":"Biochim Biophys Acta"},{"key":"435_CR101","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3001059","volume":"2","author":"B Zheng","year":"2010","unstructured":"Zheng B, Liao Z, Locascio JJ, Lesniak KA, Roderick SS, Watt ML, et al. PGC-1\u03b1, a potential therapeutic target for early intervention in Parkinson\u2019s disease. Sci Transl Med. 2010;2: 52ra73.","journal-title":"Sci Transl Med"},{"key":"435_CR102","doi-asserted-by":"publisher","first-page":"12753","DOI":"10.1074\/jbc.273.21.12753","volume":"273","author":"GP Davey","year":"1998","unstructured":"Davey GP, Peuchen S, Clark JB. Energy thresholds in brain mitochondria. Potential involvement in neurodegeneration. J Biol Chem. 1998;273:12753\u20137.","journal-title":"J Biol Chem"},{"key":"435_CR103","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.neulet.2009.11.065","volume":"469","author":"C Isobe","year":"2010","unstructured":"Isobe C, Abe T, Terayama Y. Levels of reduced and oxidized coenzyme Q-10 and 8-hydroxy-2\u2032-deoxyguanosine in the cerebrospinal fluid of patients with living Parkinson\u2019s disease demonstrate that mitochondrial oxidative damage and\/or oxidative DNA damage contributes to the neurodegenerative process. Neurosci Lett. 2010;469:159\u201363.","journal-title":"Neurosci Lett"},{"key":"435_CR104","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1111\/j.1471-4159.1990.tb02325.x","volume":"54","author":"AHV Schapira","year":"1990","unstructured":"Schapira AHV, Cooper JM, Dexter D, Cark JB, Jenner P, Marsden CD. Mitochondrial complex I deficiency in Parkinson\u2019s disease. J Neurochem. 1990;54:823\u20137.","journal-title":"J Neurochem"},{"key":"435_CR105","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/0022-510X(91)90311-T","volume":"104","author":"LA Bindoff","year":"1991","unstructured":"Bindoff LA, Birch-Machin MA, Cartlidge NE, Parker WD Jr, Turnbull DM. Respiratory chain abnormalities in skeletal muscle from patients with Parkinson\u2019s disease. J Neurol Sci. 1991;104:203\u20138.","journal-title":"J Neurol Sci"},{"key":"435_CR106","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1002\/ana.410260606","volume":"26","author":"WD Parker Jr","year":"1989","unstructured":"Parker WD Jr, Boyson SJ, Parks JK. Abnormalities of the electron transport chain in idiopathic Parkinson\u2019s disease. Ann Neurol. 1989;26:719\u201323.","journal-title":"Ann Neurol"},{"key":"435_CR107","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1006\/exnr.2000.7333","volume":"162","author":"PA Trimmer","year":"2000","unstructured":"Trimmer PA, Swerdlow RH, Parks JK, Keeney P, Bennett JP Jr, Miller SW, et al. Abnormal mitochondrial morphology in sporadic Parkinson\u2019s and Alzheimer\u2019s disease cybrid cell lines. Exp Neurol. 2000;162:37\u201350.","journal-title":"Exp Neurol"},{"key":"435_CR108","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/ng1778","volume":"38","author":"Y Kraytsberg","year":"2006","unstructured":"Kraytsberg Y, Kudryavtseva E, McKee AC, Geula C, Kowall NW, Khrapko K. Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons. Nat Genet. 2006;38:518\u201320.","journal-title":"Nat Genet"},{"key":"435_CR109","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, et al. MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord. 2015;30:1591\u2013601.","journal-title":"Mov Disord"},{"key":"435_CR110","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1586\/14737175.2016.1135056","volume":"16","author":"MA Algarni","year":"2016","unstructured":"Algarni MA, Stoessl AJ. The role of biomarkers and imaging in Parkinson\u2019s disease. Expert Rev Neurother. 2016;16:187\u2013203.","journal-title":"Expert Rev Neurother"},{"key":"435_CR111","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1097\/JOM.0b013e31827f37f8","volume":"55","author":"X Vergara","year":"2013","unstructured":"Vergara X, Kheifets L, Greenland S, Oksuzyan S, Cho Y, Mezei G. Occupational exposure to extremely low-frequency magnetic fields and neurodegenerative disease: a meta-analysis. J Occup Environ Med. 2013;55:135\u201346.","journal-title":"J Occup Environ Med"},{"key":"435_CR112","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1212\/WNL.0b013e3181c1df48","volume":"73","author":"C Armon","year":"2009","unstructured":"Armon C. Smoking may be considered an established risk factor for sporadic ALS. Neurology. 2009;73:1693\u20138.","journal-title":"Neurology"},{"key":"435_CR113","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1002\/ana.24150","volume":"75","author":"E Pupillo","year":"2014","unstructured":"Pupillo E, Messina P, Giussani G, Logroscino G, Zoccolella S, Chi\u00f2 A, et al. Physical activity and amyotrophic lateral sclerosis: a European population-based case-control study. Ann Neurol. 2014;75:708\u201316.","journal-title":"Ann Neurol"},{"key":"435_CR114","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1136\/jnnp.2010.218982","volume":"83","author":"P Mattsson","year":"2012","unstructured":"Mattsson P, L\u00f6nnstedt I, Nygren I, Askmark H. Physical fitness, but not muscle strength, is a risk factor for death in amyotrophic lateral sclerosis at an early age. J Neurol Neurosurg Psychiatry. 2012;83:390\u20134.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"435_CR115","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.neuron.2016.09.015","volume":"92","author":"R Lopez-Gonzalez","year":"2016","unstructured":"Lopez-Gonzalez R, Lu Y, Gendron TF, Karydas A, Tran H, Yang D, et al. Poly(GR) in C9ORF72-related ALS\/FTD compromises mitochondrial function and increases oxidative stress and DNA damage in iPSC-derived motor neurons. Neuron. 2016;92:383\u201391.","journal-title":"Neuron"},{"key":"435_CR116","doi-asserted-by":"publisher","first-page":"3241","DOI":"10.1523\/JNEUROSCI.18-09-03241.1998","volume":"18","author":"J Kong","year":"1998","unstructured":"Kong J, Xu Z. Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1. J Neurosci. 1998;18:3241\u201350.","journal-title":"J Neurosci"},{"key":"435_CR117","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1005357","volume":"11","author":"J Deng","year":"2015","unstructured":"Deng J, Yang M, Chen Y, Chen X, Liu J, Sun S, et al. FUS Interacts with HSP60 to promote mitochondrial damage. PLoS Genet. 2015;11: e1005357.","journal-title":"PLoS Genet"},{"key":"435_CR118","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.nmd.2011.08.003","volume":"22","author":"A Conte","year":"2012","unstructured":"Conte A, Lattante S, Zollino M, Marangi G, Luigetti M, Del Grande A, et al. P525L FUS mutation is consistently associated with a severe form of juvenile amyotrophic lateral sclerosis. Neuromuscul Disord. 2012;22:73\u20135.","journal-title":"Neuromuscul Disord"},{"key":"435_CR119","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/nen.0b013e31802c396b","volume":"66","author":"S Sasaki","year":"2007","unstructured":"Sasaki S, Iwata M. Mitochondrial alterations in the spinal cord of patients with sporadic amyotrophic lateral sclerosis. J Neuropathol Exp Neurol. 2007;66:10\u20136.","journal-title":"J Neuropathol Exp Neurol"},{"key":"435_CR120","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.nbd.2017.02.004","volume":"105","author":"KJ De Vos","year":"2017","unstructured":"De Vos KJ, Hafezparast M. Neurobiology of axonal transport defects in motor neuron diseases: Opportunities for translational research? Neurobiol Dis. 2017;105:283\u201399.","journal-title":"Neurobiol Dis"},{"key":"435_CR121","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1046\/j.0022-3042.2001.00731.x","volume":"80","author":"FR Wiedemann","year":"2002","unstructured":"Wiedemann FR, Manfredi G, Mawrin C, Beal MF, Schon EA. Mitochondrial DNA and respiratory chain function in spinal cords of ALS patients. J Neurochem. 2002;80:616\u201325.","journal-title":"J Neurochem"},{"key":"435_CR122","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1179\/1743132812Y.0000000012","volume":"34","author":"P Ghiasi","year":"2012","unstructured":"Ghiasi P, Hosseinkhani S, Noori A, Nafissi S, Khajeh K. Mitochondrial complex I deficiency and ATP\/ADP ratio in lymphocytes of amyotrophic lateral sclerosis patients. Neurol Res. 2012;34:297\u2013303.","journal-title":"Neurol Res"},{"key":"435_CR123","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/ana.410390210","volume":"39","author":"L Sikl\u00f3s","year":"1996","unstructured":"Sikl\u00f3s L, Engelhardt J, Harati Y, Smith RG, Jo\u00f3 F, Appel SH. Ultrastructural evidence for altered calcium in motor nerve terminals in amyotrophic lateral sclerosis. Ann Neurol. 1996;39:203\u201316.","journal-title":"Ann Neurol"},{"key":"435_CR124","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0022-510X(98)00008-2","volume":"156","author":"FR Wiedemann","year":"1998","unstructured":"Wiedemann FR, Winkler K, Kuznetsov AV, Bartels C, Vielhaber S, Feistner H, et al. Impairment of mitochondrial function in skeletal muscle of patients with amyotrophic lateral sclerosis. J Neurol Sci. 1998;156:65\u201372.","journal-title":"J Neurol Sci"},{"key":"435_CR125","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1001\/archneurol.2010.128","volume":"67","author":"V Crugnola","year":"2010","unstructured":"Crugnola V, Lamperti C, Lucchini V, Ronchi D, Peverelli L, Prelle A, et al. Mitochondrial respiratory chain dysfunction in muscle from patients with amyotrophic lateral sclerosis. Arch Neurol. 2010;67:849\u201354.","journal-title":"Arch Neurol"},{"key":"435_CR126","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1007\/s00259-016-3440-3","volume":"43","author":"C Marini","year":"2016","unstructured":"Marini C, Cistaro A, Campi C, Calvo A, Caponnetto C, Nobili FM, et al. A PET\/CT approach to spinal cord metabolism in amyotrophic lateral sclerosis. Eur J Nucl Med Mol Imaging. 2016;43:2061\u201371.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"435_CR127","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13550-020-0607-5","volume":"10","author":"M Bauckneht","year":"2020","unstructured":"Bauckneht M, Lai R, Miceli A, Schenone D, Cossu V, Donegani MI, et al. Spinal cord hypermetabolism extends to skeletal muscle in amyotrophic lateral sclerosis: a computational approach to [18F]-fluorodeoxyglucose PET\/CT images. EJNMMI Res. 2020;10:23.","journal-title":"EJNMMI Res"},{"key":"435_CR128","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1016\/j.clinph.2020.04.005","volume":"131","author":"JM Shefner","year":"2020","unstructured":"Shefner JM, Al-Chalabi A, Baker MR, Cui L, de Carvalho M, Eisen A, et al. A proposal for new diagnostic criteria for ALS. Clin Neurophysiol. 2020;131:1975\u20138.","journal-title":"Clin Neurophysiol"},{"key":"435_CR129","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s13311-010-0011-3","volume":"8","author":"S Wang","year":"2011","unstructured":"Wang S, Melhem ER, Poptani H, Woo JH. Neuroimaging in amyotrophic lateral sclerosis. Neurotherapeutics. 2011;8:63\u201371.","journal-title":"Neurotherapeutics"},{"key":"435_CR130","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1097\/WCO.0000000000000854","volume":"33","author":"N Verber","year":"2020","unstructured":"Verber N, Shaw PJ. Biomarkers in amyotrophic lateral sclerosis: a review of new developments. Curr Opin Neurol. 2020;33:662\u20138.","journal-title":"Curr Opin Neurol"},{"key":"435_CR131","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3233\/JHD-130082","volume":"2","author":"CM Sousa","year":"2013","unstructured":"Sousa CM, Humbert S. Huntingtin: Here, there, everywhere! J Huntingt Dis. 2013;2:395\u2013403.","journal-title":"J Huntingt Dis"},{"key":"435_CR132","doi-asserted-by":"publisher","first-page":"17269","DOI":"10.1038\/s41598-020-74042-8","volume":"10","author":"GC O\u2019Regan","year":"2020","unstructured":"O\u2019Regan GC, Farag SH, Ostroff GR, Tabrizi SJ, Andre R. Wild-type huntingtin regulates human macrophage function. Sci Rep. 2020;10:17269.","journal-title":"Sci Rep"},{"key":"435_CR133","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/ng1219","volume":"35","author":"C Zuccato","year":"2003","unstructured":"Zuccato C, Tartari M, Crotti A, Goffredo D, Valenza M, Conti L, et al. Huntingtin interacts with REST\/NRSF to modulate the transcription of NRSE-controlled neuronal genes. Nat Genet. 2003;35:76\u201383.","journal-title":"Nat Genet"},{"key":"435_CR134","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.ydbio.2014.04.005","volume":"391","author":"I Ismailoglu","year":"2014","unstructured":"Ismailoglu I, Chen Q, Popowski M, Yang L, Gross SS, Brivanlou AH. Huntingtin protein is essential for mitochondrial metabolism, bioenergetics and structure in murine embryonic stem cells. Dev Biol. 2014;391:230\u201340.","journal-title":"Dev Biol"},{"key":"435_CR135","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1111\/j.1460-9568.2008.06310.x","volume":"27","author":"JM Gil","year":"2008","unstructured":"Gil JM, Rego AC. Mechanisms of neurodegeneration in Huntington\u2019s disease. Eur J Neurosci. 2008;27:2803\u201320.","journal-title":"Eur J Neurosci"},{"key":"435_CR136","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.neubiorev.2015.03.003","volume":"52","author":"C Mo","year":"2015","unstructured":"Mo C, Hannan AJ, Renoir T. Environmental factors as modulators of neurodegeneration: insights from gene-environment interactions in Huntington\u2019s disease. Neurosci Biobehav Rev. 2015;52:178\u201392.","journal-title":"Neurosci Biobehav Rev"},{"key":"435_CR137","doi-asserted-by":"publisher","first-page":"3498","DOI":"10.1073\/pnas.0308679101","volume":"101","author":"NS Wexler","year":"2004","unstructured":"Wexler NS, Lorimer J, Porter J, Gomez F, Moskowitz C, Shackell E, et al. Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington\u2019s disease age of onset. Proc Natl Acad Sci USA. 2004;101:3498\u2013503.","journal-title":"Proc Natl Acad Sci USA"},{"key":"435_CR138","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/ajmg.a.20328","volume":"124A","author":"MH Anca","year":"2004","unstructured":"Anca MH, Gazit E, Loewenthal R, Ostrovsky O, Frydman M, Giladi N. Different phenotypic expression in monozygotic twins with Huntington disease. Am J Med Genet A. 2004;124A:89\u201391.","journal-title":"Am J Med Genet A"},{"key":"435_CR139","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1001\/archneur.62.6.995","volume":"62","author":"JH Friedman","year":"2005","unstructured":"Friedman JH, Trieschmann ME, Myers RH, Fernandez HH. Monozygotic twins discordant for Huntington disease after 7 years. Arch Neurol. 2005;62:995\u20137.","journal-title":"Arch Neurol"},{"key":"435_CR140","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1111\/j.1471-4159.1993.tb03633.x","volume":"61","author":"MF Beal","year":"1993","unstructured":"Beal MF, Brouillet E, Jenkins B, Henshaw R, Rosen B, Hyman BT. Age-dependent striatal excitotoxic lesions produced by the endogenous mitochondrial inhibitor malonate. J Neurochem. 1993;61:1147\u201350.","journal-title":"J Neurochem"},{"key":"435_CR141","first-page":"1382","volume":"70","author":"K Marder","year":"2013","unstructured":"Marder K, Gu Y, Eberly S, Tanner CM, Scarmeas N, Oakes D, et al. Relationship of Mediterranean diet and caloric intake to phenoconversion in Huntington disease. JAMA Neurol. 2013;70:1382\u20138.","journal-title":"JAMA Neurol"},{"key":"435_CR142","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1002\/mds.23108","volume":"25","author":"MK Trembath","year":"2010","unstructured":"Trembath MK, Horton ZA, Tippett L, Collins VR, Churchyard A, Velakoulis D, et al. A retrospective study of the impact of lifestyle on age at onset of Huntington disease. Mov Disord. 2010;25:1444\u201350.","journal-title":"Mov Disord"},{"key":"435_CR143","doi-asserted-by":"publisher","first-page":"3919","DOI":"10.1093\/hmg\/ddq306","volume":"19","author":"J Kim","year":"2010","unstructured":"Kim J, Moody JP, Edgerly CK, Bordiuk OL, Cormier K, Smith K, et al. Mitochondrial loss, dysfunction and altered dynamics in Huntington\u2019s disease. Hum Mol Genet. 2010;19:3919\u201335.","journal-title":"Hum Mol Genet"},{"key":"435_CR144","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1093\/hmg\/ddr024","volume":"20","author":"U Shirendeb","year":"2011","unstructured":"Shirendeb U, Reddy AP, Manczak M, Calkins MJ, Mao P, Tagle DA, et al. Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington\u2019s disease: implications for selective neuronal damage. Hum Mol Genet. 2011;20:1438\u201355.","journal-title":"Hum Mol Genet"},{"key":"435_CR145","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.cell.2006.09.015","volume":"127","author":"L Cui","year":"2006","unstructured":"Cui L, Jeong H, Borovecki F, Parkhurst CN, Tanese N, Krainc D. Transcriptional repression of PGC-1\u03b1 by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration. Cell. 2006;127:59\u201369.","journal-title":"Cell"},{"key":"435_CR146","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1002\/mds.20373","volume":"20","author":"C Saft","year":"2005","unstructured":"Saft C, Zange J, Andrich J, M\u00fcller K, Lindenberg K, Landwehrmeyer B, et al. Mitochondrial impairment in patients and asymptomatic mutation carriers of Huntington\u2019s disease. Mov Disord. 2005;20:674\u20139.","journal-title":"Mov Disord"},{"key":"435_CR147","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nn884","volume":"5","author":"AV Panov","year":"2002","unstructured":"Panov AV, Gutekunst C, Leavitt BR, Hayden MR, Burke JR, Strittmatter WJ, et al. Early mitochondrial calcium defects in Huntington\u2019s disease are a direct effect of polyglutamines. Nat Neurosci. 2002;5:731\u20136.","journal-title":"Nat Neurosci"},{"key":"435_CR148","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/ana.410410514","volume":"41","author":"SE Browne","year":"1997","unstructured":"Browne SE, Bowling AC, MacGarvey U, Baik MJ, Berger SC, Muqit MK, et al. Oxidative damage and metabolic dysfunction in Huntington\u2019s disease: selective vulnerability of the basal ganglia. Ann Neurol. 1997;41:646\u201353.","journal-title":"Ann Neurol"},{"key":"435_CR149","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/ana.410430321","volume":"43","author":"J Arenas","year":"1998","unstructured":"Arenas J, Campos Y, Ribacoba R, Martin MA, Rubio JC, Ablanedo P, et al. Complex I defect in muscle from patients with Huntington\u2019s disease. Ann Neurol. 1998;43:397\u2013400.","journal-title":"Ann Neurol"},{"issue":"33","key":"435_CR150","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1097\/00005072-197404000-00008","volume":"1974","author":"I Tellez-Nagel","year":"1974","unstructured":"Tellez-Nagel I, Johnson AB, Terry RD. Studies on brain biopsies of patients with Huntington\u2019s chorea. J Neuropathol Exp Neurol. 1974;1974(33):308\u201332.","journal-title":"J Neuropathol Exp Neurol"},{"key":"435_CR151","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0304-3940(99)00578-9","volume":"272","author":"MC Polidori","year":"1999","unstructured":"Polidori MC, Mecocci P, Browne SE, Senin U, Beal MF. Oxidative damage to mitochondrial DNA in Huntington\u2019s disease parietal cortex. Neurosci Lett. 1999;272:53\u20136.","journal-title":"Neurosci Lett"},{"key":"435_CR152","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1001\/jamaneurol.2017.1200","volume":"74","author":"V Gaura","year":"2017","unstructured":"Gaura V, Lavisse S, Payoux P, Goldman S, Verny C, Krystkowiak P, et al. Association between motor symptoms and brain metabolism in early Huntington disease. JAMA Neurol. 2017;74:1088\u201396.","journal-title":"JAMA Neurol"},{"key":"435_CR153","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/ene.13413","volume":"25","author":"P McColgan","year":"2018","unstructured":"McColgan P, Tabrizi SJ. Huntington\u2019s disease: a clinical review. Eur J Neurol. 2018;25:24\u201334.","journal-title":"Eur J Neurol"},{"key":"435_CR154","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S1474-4422(11)70070-9","volume":"10","author":"DW Weir","year":"2011","unstructured":"Weir DW, Sturrock A, Leavitt BR. Development of biomarkers for Huntington\u2019s disease. Lancet Neurol. 2011;10:573\u201390.","journal-title":"Lancet Neurol"},{"key":"435_CR155","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3233\/JHD-170273","volume":"7","author":"E Silajd\u017ei\u0107","year":"2018","unstructured":"Silajd\u017ei\u0107 E, Bj\u00f6rkqvist M. A critical evaluation of wet biomarkers for Huntington\u2019s disease: current status and ways forward. J Huntingt Dis. 2018;7:109\u201335.","journal-title":"J Huntingt Dis"},{"key":"435_CR156","first-page":"517","volume":"33","author":"CM Southam","year":"1943","unstructured":"Southam CM, Ehrlich J. Effects of extract of western red-cedar heartwood on certain wood-decaying fungi in culture. Phytopathol. 1943;33:517\u201324.","journal-title":"Phytopathol"},{"key":"435_CR157","doi-asserted-by":"publisher","first-page":"288","DOI":"10.2203\/dose-response.13-035.Ristow","volume":"12","author":"M Ristow","year":"2014","unstructured":"Ristow M, Schmeisser K. Mitohormesis: promoting health and lifespan by increased levels of reactive oxygen species (ROS). Dose Response. 2014;12:288\u2013341.","journal-title":"Dose Response"},{"key":"435_CR158","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1093\/geronj\/11.3.298","volume":"11","author":"D Harman","year":"1956","unstructured":"Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol. 1956;11:298\u2013300.","journal-title":"J Gerontol"},{"key":"435_CR159","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/j.1532-5415.1972.tb00787.x","volume":"20","author":"D Harman","year":"1972","unstructured":"Harman D. The biologic clock: The mitochondria? J Am Geriatr Soc. 1972;20:145\u20137.","journal-title":"J Am Geriatr Soc"},{"key":"435_CR160","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.cmet.2015.05.013","volume":"22","author":"NS Chandel","year":"2015","unstructured":"Chandel NS. Evolution of mitochondria as signaling organelles. Cell Metab. 2015;22:204\u20136.","journal-title":"Cell Metab"},{"key":"435_CR161","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/S0955-0674(98)80147-6","volume":"10","author":"T Finkel","year":"1998","unstructured":"Finkel T. Oxygen radicals and signaling. Curr Opin Cell Biol. 1998;10:248\u201353.","journal-title":"Curr Opin Cell Biol"},{"key":"435_CR162","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.molcel.2012.09.025","volume":"48","author":"LA Sena","year":"2012","unstructured":"Sena LA, Chandel NS. Physiological roles of mitochondrial reactive oxygen species. Mol Cell. 2012;48:158\u201367.","journal-title":"Mol Cell"},{"key":"435_CR163","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.mehy.2005.09.009","volume":"66","author":"PC Tapia","year":"2006","unstructured":"Tapia PC. Sublethal mitochondrial stress with an attendant stoichiometric augmentation of reactive oxygen species may precipitate many of the beneficial alterations in cellular physiology produced by caloric restriction, intermittent fasting, exercise and dietary phytonutrients: \u2018mitohormesis\u2019 for health and vitality. Med Hypotheses. 2006;66:832\u201343.","journal-title":"Med Hypotheses"},{"key":"435_CR164","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.cmet.2014.01.011","volume":"19","author":"J Yun","year":"2014","unstructured":"Yun J, Finkel T. Mitohormesis. Cell Metab. 2014;19:757\u201366.","journal-title":"Cell Metab"},{"key":"435_CR165","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1016\/j.cmet.2023.10.011","volume":"35","author":"YW Cheng","year":"2023","unstructured":"Cheng YW, Liu J, Finkel T. Mitohormesis. Cell Metab. 2023;35:1872\u201386.","journal-title":"Cell Metab"},{"key":"435_CR166","doi-asserted-by":"publisher","first-page":"568","DOI":"10.4093\/dmj.2019.0143","volume":"43","author":"Y Lee","year":"2019","unstructured":"Lee Y, Lee D. Mitochondrial toxins and healthy lifestyle meet at the crossroad of hormesis. Diabetes Metab J. 2019;43:568\u201377.","journal-title":"Diabetes Metab J"},{"key":"435_CR167","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.arr.2007.04.003","volume":"7","author":"F Gomez-Pinilla","year":"2008","unstructured":"Gomez-Pinilla F. The influences of diet and exercise on mental health through hormesis. Aging Res Rev. 2008;7:49\u201362.","journal-title":"Aging Res Rev"},{"key":"435_CR168","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.arr.2007.03.002","volume":"7","author":"SIS Rattan","year":"2008","unstructured":"Rattan SIS. Hormesis in aging. Ageing Res Rev. 2008;7:63\u201378.","journal-title":"Ageing Res Rev"},{"key":"435_CR169","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.envpol.2017.10.124","volume":"233","author":"S Kim","year":"2018","unstructured":"Kim S, Lee Y, Choi J, Jacobs DR Jr, Lee D. Evolutionarily adapted hormesis-inducing stressors can be a practical solution to mitigate harmful effects of chronic exposure to low dose chemical mixtures. Environ Pollut. 2018;233:725\u201334.","journal-title":"Environ Pollut"},{"key":"435_CR170","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1146\/annurev-micro-032921-123231","volume":"75","author":"YP Li","year":"2021","unstructured":"Li YP, Fekih IB, Fru EC, Moraleda-Munoz A, Li X, Rosen BP, et al. Antimicrobial activity of metals and metalloids. Annu Rev Microbiol. 2021;75:175\u201397.","journal-title":"Annu Rev Microbiol"},{"key":"435_CR171","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.669379","volume":"9","author":"Z Rong","year":"2021","unstructured":"Rong Z, Tu P, Xu P, Sun Y, Yu F, Tu N, et al. The mitochondrial response to DNA damage. Front Cell Dev Biol. 2021;9: 669379.","journal-title":"Front Cell Dev Biol"},{"key":"435_CR172","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.tox.2017.07.019","volume":"391","author":"JN Meyer","year":"2017","unstructured":"Meyer JN, Leuthner TC, Luz AL. Mitochondrial fusion, fission, and mitochondrial toxicity. Toxicology. 2017;391:42\u201353.","journal-title":"Toxicology"},{"key":"435_CR173","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.2003066","volume":"15","author":"BP Lanphear","year":"2017","unstructured":"Lanphear BP. Low-level toxicity of chemicals: No acceptable levels? PLoS Biol. 2017;15: e2003066.","journal-title":"PLoS Biol"},{"key":"435_CR174","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41514-017-0013-z","volume":"3","author":"EJ Calabrese","year":"2017","unstructured":"Calabrese EJ, Mattson MP. How does hormesis impact biology, toxicology, and medicine? NPJ Aging Mech Dis. 2017;3:13.","journal-title":"NPJ Aging Mech Dis"},{"key":"435_CR175","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jclinepi.2018.12.005","volume":"107","author":"D Lee","year":"2019","unstructured":"Lee D, Jacobs DR Jr. Firm human evidence on harms of endocrine-disrupting chemicals was unlikely to be obtainable for methodological reasons. J Clin Epidemiol. 2019;107:107\u201315.","journal-title":"J Clin Epidemiol"},{"issue":"Suppl 63","key":"435_CR176","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1002\/ajpa.23148","volume":"162","author":"AN Crittenden","year":"2017","unstructured":"Crittenden AN, Schnorr SL. Current views on hunter\u2013gatherer nutrition and the evolution of the human diet. Am J Phys Anthropol. 2017;162(Suppl 63):84\u2013109.","journal-title":"Am J Phys Anthropol"},{"key":"435_CR177","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.bbabio.2010.02.016","volume":"1797","author":"MA Aon","year":"2010","unstructured":"Aon MA, Cortassa S, O\u2019Rourke B. Redox-optimized ROS balance: a unifying hypothesis. Biochim Biophys Acta. 2010;1797:865\u201377.","journal-title":"Biochim Biophys Acta"},{"key":"435_CR178","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/137919","volume":"2014","author":"LJ Yan","year":"2014","unstructured":"Yan LJ. Pathogenesis of chronic hyperglycemia: from reductive stress to oxidative stress. J Diabetes Res. 2014;2014: 137919.","journal-title":"J Diabetes Res"},{"key":"435_CR179","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1126\/science.aau2096","volume":"362","author":"DS Ludwig","year":"2018","unstructured":"Ludwig DS, Willett WC, Volek JS, Neuhouser ML. Dietary fat: From foe to friend? Science. 2018;362:764\u201370.","journal-title":"Science"},{"issue":"19","key":"435_CR180","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/s41573-020-0072-x","volume":"2020","author":"SC Cunnane","year":"2020","unstructured":"Cunnane SC, Trushina E, Morland C, Prigione A, Casadesus G, Andrews ZB, et al. Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing. Nat Rev Drug Discov. 2020;2020(19):609\u201333.","journal-title":"Nat Rev Drug Discov"},{"key":"435_CR181","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/nyas.12999","volume":"1367","author":"SC Cunnane","year":"2016","unstructured":"Cunnane SC, Courchesne-Loyer A, St-Pierre V, Valdenberghe C, Pierotti T, Fortier M, et al. Can ketones compensate for deteriorating brain glucose uptake during aging? Implications for the risk and treatment of Alzheimer\u2019s disease. Ann N Y Acad Sci. 2016;1367:12\u201320.","journal-title":"Ann N Y Acad Sci"},{"key":"435_CR182","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1056\/NEJMra1905136","volume":"381","author":"R de Cabo","year":"2019","unstructured":"de Cabo R, Mattson MP. Effects of intermittent fasting on health, aging, and disease. N Engl J Med. 2019;381:2541\u201351.","journal-title":"N Engl J Med"},{"key":"435_CR183","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1194\/jlr.R048975","volume":"55","author":"LB Gano","year":"2014","unstructured":"Gano LB, Patel M, Rho JM. Ketogenic diets, mitochondria, and neurological diseases. J Lipid Res. 2014;55:2211\u201328.","journal-title":"J Lipid Res"},{"key":"435_CR184","first-page":"28","volume":"4","author":"MK Taylor","year":"2018","unstructured":"Taylor MK, Sullivan DK, Mahnken JD, Burns JM, Swerdlow RH. Feasibility and efficacy data from a ketogenic diet intervention in Alzheimer\u2019s disease. Alzheimers Dement. 2018;4:28\u201336.","journal-title":"Alzheimers Dement"},{"key":"435_CR185","doi-asserted-by":"publisher","first-page":"969","DOI":"10.3233\/JAD-180995","volume":"68","author":"J Brandt","year":"2019","unstructured":"Brandt J, Buchholz A, Henry-Barron B, Vizthum D, Avramopoulos D, Cervenka MC. Preliminary report on the feasibility and efficacy of the modified Atkins diet for treatment of mild cognitive impairment and early Alzheimer\u2019s disease. J Alzheimers Dis. 2019;68:969\u201381.","journal-title":"J Alzheimers Dis"},{"key":"435_CR186","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13195-021-00783-x","volume":"13","author":"MCL Phillips","year":"2021","unstructured":"Phillips MCL, Deprez LM, Mortimer GMN, Murtagh DKJ, McCoy S, Mylchreest R, et al. Randomized crossover trial of a modified ketogenic diet in Alzheimer\u2019s disease. Alzheimers Res Ther. 2021;13:51.","journal-title":"Alzheimers Res Ther"},{"key":"435_CR187","doi-asserted-by":"publisher","first-page":"1182519","DOI":"10.3389\/fendo.2024.1182519","volume":"15","author":"A Buchholz","year":"2024","unstructured":"Buchholz A, Deme P, Betz JF, Brandt J, Haughey N, Cervenka MC. A randomized feasibility trial of the modified Atkins diet in older adults with mild cognitive impairment due to Alzheimer\u2019s disease. Front Endocrinol. 2024;15:1182519.","journal-title":"Front Endocrinol"},{"key":"435_CR188","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1212\/01.WNL.0000152046.11390.45","volume":"64","author":"TB Vanitallie","year":"2005","unstructured":"Vanitallie TB, Nonas C, Di Rocco A, Boyar K, Hyams K, Heymsfield SB. Treatment of Parkinson disease with diet-induced hyperketonemia: a feasibility study. Neurology. 2005;64:728\u201330.","journal-title":"Neurology"},{"key":"435_CR189","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1002\/mds.27390","volume":"33","author":"MCL Phillips","year":"2018","unstructured":"Phillips MCL, Murtagh DKJ, Gilbertson LJ, Asztely FJS, Lynch CDP. Low-fat versus ketogenic diet in Parkinson\u2019s disease: a pilot randomized controlled trial. Mov Disord. 2018;33:1306\u201314.","journal-title":"Mov Disord"},{"key":"435_CR190","first-page":"41","volume":"1","author":"R Krikorian","year":"2019","unstructured":"Krikorian R, Shidler MD, Summer SS, Sullivan PG, Duker AP, Isaacson RS, Espay AJ. Nutritional ketosis for mild cognitive impairment in Parkinson\u2019s disease: a controlled pilot trial. Clin Park Relat Disord. 2019;1:41\u20137.","journal-title":"Clin Park Relat Disord"},{"key":"435_CR191","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s12883-024-03603-5","volume":"24","author":"AH Choi","year":"2024","unstructured":"Choi AH, Delgado M, Chen KY, Chung ST, Courville A, Turner SA, et al. A randomized feasibility trial of medium chain triglyceride-supplemented ketogenic diet in people with Parkinson\u2019s disease. BMC Neurol. 2024;24:106.","journal-title":"BMC Neurol"},{"key":"435_CR192","doi-asserted-by":"publisher","first-page":"1329541","DOI":"10.3389\/fneur.2023.1329541","volume":"14","author":"MCL Phillips","year":"2024","unstructured":"Phillips MCL, Johnston SE, Simpson P, Chang DK, Mather D, Dick RJ. Time-restricted ketogenic diet in amyotrophic lateral sclerosis: a case study. Front Neurol. 2024;14:1329541.","journal-title":"Front Neurol"},{"key":"435_CR193","doi-asserted-by":"publisher","DOI":"10.3389\/fnbeh.2022.931636","volume":"16","author":"MCL Phillips","year":"2022","unstructured":"Phillips MCL, McManus EJ, Brinkhuis M, Romero-Ferrando B. Time-restricted ketogenic diet in Huntington\u2019s disease: a case study. Front Behav Neurosci. 2022;16: 931636.","journal-title":"Front Behav Neurosci"},{"key":"435_CR194","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1093\/advances\/nmaa053","volume":"11","author":"J Barbaresko","year":"2020","unstructured":"Barbaresko J, Lellmann AW, Schmidt A, Lehmann A, Amini AM, Egert S, et al. Dietary factors and neurodegenerative disorders: an umbrella review of meta-analyses of prospective studies. Adv Nutr. 2020;11:1161\u201373.","journal-title":"Adv Nutr"},{"key":"435_CR195","doi-asserted-by":"publisher","first-page":"889","DOI":"10.3945\/an.116.012138","volume":"7","author":"SD Petersson","year":"2016","unstructured":"Petersson SD, Philippou E. Mediterranean diet, cognitive function, and dementia: a systematic review of the evidence. Adv Nutr. 2016;7:889\u2013904.","journal-title":"Adv Nutr"},{"key":"435_CR196","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s43587-020-00013-3","volume":"1","author":"VD Longo","year":"2021","unstructured":"Longo VD, Di Tano M, Mattson MP, Guidi N. Intermittent and periodic fasting, longevity and disease. Nat Aging. 2021;1:47\u201359.","journal-title":"Nat Aging"},{"key":"435_CR197","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.15252\/embj.201695810","volume":"36","author":"S Camandola","year":"2017","unstructured":"Camandola S, Mattson MP. Brain metabolism in health, aging, and neurodegeneration. EMBO J. 2017;36:1474\u201392.","journal-title":"EMBO J"},{"key":"435_CR198","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40035-024-00406-z","volume":"13","author":"RG Wells","year":"2024","unstructured":"Wells RG, Neilson LE, McHill AW, Hiller AL. Dietary fasting and time-restricted eating in Huntington\u2019s disease: therapeutic potential and underlying mechanisms. Transl Neurodegener. 2024;13:17.","journal-title":"Transl Neurodegener"},{"key":"435_CR199","doi-asserted-by":"publisher","DOI":"10.1101\/2023.10.06.559575","author":"C Trumpff","year":"2023","unstructured":"Trumpff C, Monzel AS, Sandi C, Menon V, Klein H, Fujita M, et al. Psychosocial experiences are associated with human brain mitochondrial biology. bioRxiv. 2023. https:\/\/doi.org\/10.1101\/2023.10.06.559575.","journal-title":"bioRxiv"},{"key":"435_CR200","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2147\/NSS.S18891","volume":"4","author":"T Shochat","year":"2012","unstructured":"Shochat T. Impact of lifestyle and technology developments on sleep. Nat Sci Sleep. 2012;4:19\u201331.","journal-title":"Nat Sci Sleep"},{"key":"435_CR201","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1037\/rev0000453","volume":"131","author":"AD Crosswell","year":"2024","unstructured":"Crosswell AD, Mayer SE, Whitehurst LN, Picard M, Zebarjadian S, Epel ES. Deep rest: an integrative model of how contemplative practices combat stress and enhance the body\u2019s restorative capacity. Psychol Rev. 2024;131:247\u201370.","journal-title":"Psychol Rev"},{"key":"435_CR202","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1073\/pnas.0438019100","volume":"100","author":"A Bierhaus","year":"2003","unstructured":"Bierhaus A, Wolf J, Andrassy M, Rohleder N, Humpert PM, Petrov D, et al. A mechanism converting psychosocial stress into mononuclear cell activation. Proc Natl Acad Sci USA. 2003;100:1920\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"435_CR203","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/nrn1970","volume":"7","author":"J Nithianantharajah","year":"2006","unstructured":"Nithianantharajah J, Hannan AJ. Enriched environments, experience-dependent plasticity and disorders of the nervous system. Nat Rev Neurosci. 2006;7:697\u2013709.","journal-title":"Nat Rev Neurosci"},{"key":"435_CR204","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1007\/s11065-017-9363-3","volume":"27","author":"DS Sherman","year":"2017","unstructured":"Sherman DS, Mauser J, Nuno M, Sherzai D. The efficacy of cognitive intervention in mild cognitive impairment (MCI): a meta-analysis of outcomes on neuropsychological measures. Neuropsychol Rev. 2017;27:440\u201384.","journal-title":"Neuropsychol Rev"},{"key":"435_CR205","doi-asserted-by":"publisher","first-page":"829","DOI":"10.3233\/JAD-230473","volume":"95","author":"FE Pozzi","year":"2023","unstructured":"Pozzi FE, Appollonio I, Ferrarese C, Tremolizzo L. Can traditional board games prevent or slow down cognitive impairment? A systematic review and meta-analysis. J Alzheimers Dis. 2023;95:829\u201345.","journal-title":"J Alzheimers Dis"},{"key":"435_CR206","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.312","volume":"5","author":"TM Cruickshank","year":"2015","unstructured":"Cruickshank TM, Thompson JA, Dom\u00ednguez DJF, Reyes AP, Bynevelt M, Georgiou-Karistianis N, et al. The effect of multidisciplinary rehabilitation on brain structure and cognition in Huntington\u2019s disease: an exploratory study. Brain Behav. 2015;5: e00312.","journal-title":"Brain Behav"},{"key":"435_CR207","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2020.117022","volume":"416","author":"DM Bartlett","year":"2020","unstructured":"Bartlett DM, Govus A, Rankin T, Lampit A, Feindel K, Poudel G, et al. The effects of multidisciplinary rehabilitation on neuroimaging, biological, cognitive and motor outcomes in individuals with premanifest Huntington\u2019s disease. J Neurol Sci. 2020;416: 117022.","journal-title":"J Neurol Sci"},{"key":"435_CR208","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.929781","volume":"13","author":"L Sun","year":"2022","unstructured":"Sun L, Liu T, Liu J, Gao C, Zhang X. Physical exercise and mitochondrial function: new therapeutic interventions for psychiatric and neurodegenerative disorders. Front Neurol. 2022;13: 929781.","journal-title":"Front Neurol"},{"key":"435_CR209","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1080\/10715760400013763","volume":"38","author":"H Orhan","year":"2004","unstructured":"Orhan H, van Holland B, Krab B, Moeken J, Vermeulen NPE, Hollander P, et al. Evaluation of a multi-parameter biomarker set for oxidative damage in man: increased urinary excretion of lipid, protein and DNA oxidation products after one hour of exercise. Free Radic Res. 2004;38:1269\u201379.","journal-title":"Free Radic Res"},{"key":"435_CR210","doi-asserted-by":"publisher","first-page":"R441","DOI":"10.1152\/ajpregu.2001.280.2.R441","volume":"280","author":"BT Leek","year":"2001","unstructured":"Leek BT, Mudaliar SR, Henry R, Mathieu-Costello O, Richardson RS. Effect of acute exercise on citrate synthase activity in untrained and trained human skeletal muscle. Am J Physiol Regul Integr Comp Physiol. 2001;280:R441\u20137.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"435_CR211","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.exger.2010.03.014","volume":"45","author":"M Ristow","year":"2010","unstructured":"Ristow M, Zarse K. How increased oxidative stress promotes longevity and metabolic health: the concept of mitochondrial hormesis (mitohormesis). Exp Gerontol. 2010;45:410\u20138.","journal-title":"Exp Gerontol"},{"key":"435_CR212","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2021.101479","volume":"72","author":"S L\u00f3pez-Ortiz","year":"2021","unstructured":"L\u00f3pez-Ortiz S, Valenzuela PL, Seisdedos MM, Morales JS, Vega T, Castillo-Garc\u00eda A, et al. Exercise interventions in Alzheimer\u2019s disease: a systematic review and meta-analysis of randomized controlled trials. Ageing Res Rev. 2021;72: 101479.","journal-title":"Ageing Res Rev"},{"key":"435_CR213","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1111\/ane.13579","volume":"145","author":"M Gamborg","year":"2022","unstructured":"Gamborg M, Hvid LG, Dalgas U, Langeskov-Christensen M. Parkinson\u2019s disease and intensive exercise therapy\u2014an updated systematic review and meta-analysis. Acta Neurol Scand. 2022;145:504\u201328.","journal-title":"Acta Neurol Scand"},{"key":"435_CR214","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1097\/PHM.0000000000001419","volume":"99","author":"L Meng","year":"2020","unstructured":"Meng L, Li X, Li C, Tsang RCC, Chen Y, Ge Y, et al. Effects of exercise in patients with amyotrophic lateral sclerosis: a systematic review and meta-analysis. Am J Phys Med Rehabil. 2020;99:801\u201310.","journal-title":"Am J Phys Med Rehabil"},{"key":"435_CR215","doi-asserted-by":"publisher","first-page":"601","DOI":"10.5334\/tohm.515","volume":"9","author":"SM Mueller","year":"2019","unstructured":"Mueller SM, Petersen JA, Jung HH. Exercise in Huntington\u2019s disease: current state and clinical significance. Tremor Other Hyperkinet Mov. 2019;9:601.","journal-title":"Tremor Other Hyperkinet Mov"},{"key":"435_CR216","doi-asserted-by":"publisher","first-page":"634","DOI":"10.3389\/fphys.2018.00634","volume":"9","author":"B Knechtle","year":"2018","unstructured":"Knechtle B, Nikolaidis PT. Physiology and pathophysiology in ultra-marathon running. Front Physiol. 2018;9:634.","journal-title":"Front Physiol"},{"key":"435_CR217","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/814096","volume":"2011","author":"M Picard","year":"2011","unstructured":"Picard M. Pathways to aging: the mitochondrion at the intersection of biological and psychosocial sciences. J Aging Res. 2011;2011: 814096.","journal-title":"J Aging Res"},{"key":"435_CR218","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/PSY.0000000000000545","volume":"80","author":"M Picard","year":"2018","unstructured":"Picard M, McEwen BS. Psychological stress and mitochondria: a systematic review. Psychosom Med. 2018;80:141\u201353.","journal-title":"Psychosom Med"},{"key":"435_CR219","doi-asserted-by":"publisher","first-page":"S119","DOI":"10.3233\/JAD-180501","volume":"70","author":"IEM Evans","year":"2019","unstructured":"Evans IEM, Martyr A, Collins R, Brayne C, Clare L. Social isolation and cognitive function in later life: a systematic review and meta-analysis. J Alzheimers Dis. 2019;70:S119\u201344.","journal-title":"J Alzheimers Dis"},{"key":"435_CR220","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1186\/s13643-017-0632-2","volume":"6","author":"ME Kelly","year":"2017","unstructured":"Kelly ME, Duff H, Kelly S, McHugh Power JE, Brennan S, Lawlor BA, et al. The impact of social activities, social networks, social support and social relationships on the cognitive functioning of healthy older adults: a systematic review. Syst Rev. 2017;6:259.","journal-title":"Syst Rev"},{"key":"435_CR221","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/gps.4166","volume":"30","author":"P Leung","year":"2015","unstructured":"Leung P, Orrell M, Orgeta V. Social support group interventions in people with dementia and mild cognitive impairment: a systematic review of the literature. Int J Geriatr Psychiatry. 2015;30:1\u20139.","journal-title":"Int J Geriatr Psychiatry"},{"key":"435_CR222","doi-asserted-by":"publisher","first-page":"674","DOI":"10.3390\/antiox12030674","volume":"12","author":"RB Richardson","year":"2023","unstructured":"Richardson RB, Mailloux RJ. Mitochondria need their sleep: redox, bioenergetics, and temperature regulation of circadian rhythms and the role of cysteine-mediated redox signaling, uncoupling proteins, and substrate cycles. Antioxidants (Basel). 2023;12:674.","journal-title":"Antioxidants (Basel)"},{"key":"435_CR223","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.jpsychires.2010.01.015","volume":"44","author":"AC Andreazza","year":"2010","unstructured":"Andreazza AC, Andersen ML, Alvarenga TA, De-Oliviera MR, Armani F, Ruiz FS, et al. Impairment of the mitochondrial electron transport chain due to sleep deprivation in mice. J Psychiatr Res. 2010;44:775\u201380.","journal-title":"J Psychiatr Res"},{"key":"435_CR224","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1126\/science.1241224","volume":"342","author":"L Xie","year":"2013","unstructured":"Xie L, Kang H, Xu Q, Chen MJ, Liao Y, Thiyagarajan M, et al. Sleep drives metabolite clearance from the adult brain. Science. 2013;342:373\u20137.","journal-title":"Science"},{"key":"435_CR225","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.956394","volume":"10","author":"S Mauri","year":"2022","unstructured":"Mauri S, Favaro M, Bernardo G, Mazzotta GM, Ziviani E. Mitochondrial autophagy in the sleeping brain. Front Cell Dev Biol. 2022;10: 956394.","journal-title":"Front Cell Dev Biol"},{"key":"435_CR226","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2021.101556","volume":"60","author":"AJ Scott","year":"2021","unstructured":"Scott AJ, Webb TL, Martyn-St James M, Rowse G, Weich S. Improving sleep quality leads to better mental health: a meta-analysis of randomised controlled trials. Sleep Med Rev. 2021;60: 101556.","journal-title":"Sleep Med Rev"},{"key":"435_CR227","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/s41598-022-27247-y","volume":"13","author":"GW Fincham","year":"2023","unstructured":"Fincham GW, Strauss C, Montero-Marin J, Cavanagh K. Effect of breathwork on stress and mental health: a meta-analysis of randomised-controlled trials. Sci Rep. 2023;13:432.","journal-title":"Sci Rep"},{"key":"435_CR228","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1515\/revneuro-2017-0066","volume":"29","author":"J Russell-Williams","year":"2018","unstructured":"Russell-Williams J, Jaroudi W, Perich T, Hoscheidt S, El Haj M, Moustafa AA. Mindfulness and meditation: treating cognitive impairment and reducing stress in dementia. Rev Neurosci. 2018;29:791\u2013804.","journal-title":"Rev Neurosci"},{"key":"435_CR229","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/mds.28345","volume":"36","author":"A van der Heide","year":"2021","unstructured":"van der Heide A, Meinders MJ, Speckens AEM, Peerbolte TF, Bloem BR, Helmich RC. Stress and mindfulness in Parkinson\u2019s disease: clinical effects and potential underlying mechanisms. Mov Disord. 2021;36:64\u201370.","journal-title":"Mov Disord"}],"container-title":["Translational Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40035-024-00435-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40035-024-00435-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40035-024-00435-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T01:04:17Z","timestamp":1725584657000},"score":1,"resource":{"primary":{"URL":"https:\/\/translationalneurodegeneration.biomedcentral.com\/articles\/10.1186\/s40035-024-00435-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,6]]},"references-count":229,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["435"],"URL":"https:\/\/doi.org\/10.1186\/s40035-024-00435-8","relation":{},"ISSN":["2047-9158"],"issn-type":[{"value":"2047-9158","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,6]]},"assertion":[{"value":"22 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"46"}}